☆ 4.7 Article

No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada

David N. Fisman et al.

Summary: Research in Ontario, Canada, showed that new variants of concern (VOCs) of SARS-CoV-2 have higher risks of hospitalization, ICU admission, and death compared to non-VOC strains, with the Delta variant showing the most pronounced increase in risk.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)

Add to Collection
Letter Infectious Diseases

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark

Peter Bager et al.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection
Article Multidisciplinary Sciences

Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020-May 2021

Lamprini Veneti et al.

Summary: This study in Norway found that the B.1.1.7 and B.1.351 variants of concern were associated with an increased risk of hospitalisation and admission to ICU compared to non-VOC. The findings underscore the importance of prevention, vaccination, and hospital surge capacity planning in combating the spread of these variants.

PLOS ONE (2021)

Add to Collection
Article Multidisciplinary Sciences

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Nicholas G. Davies et al.

Summary: A new variant of SARS-CoV-2 has emerged in England, with a higher reproduction number and potential for large resurgences of COVID-19 cases. Without stringent control measures, it is projected that COVID-19 hospitalizations and deaths in England for the first 6 months of 2021 will exceed those in 2020. The variant has spread globally and exhibited similar transmission increases in Denmark, Switzerland, and the United States.

SCIENCE (2021)

Add to Collection
Article Infectious Diseases

Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021

Elina Seppala et al.

Summary: This population-based cohort study found that the vaccine effectiveness against the Delta variant was significantly lower for partially vaccinated individuals at 22.4% compared to 64.6% for fully vaccinated individuals, when compared to vaccine effectiveness against the Alpha variant at 54.5% and 84.4% respectively.

EUROSURVEILLANCE (2021)

Add to Collection
Letter Medicine, General & Internal

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness

Aziz Sheikh et al.

LANCET (2021)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.